ONYX — Onyx Biotec Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹972.79m
- IN₹1.01bn
- IN₹619.51m
- 57
- 39
- 19
- 29
Annual cashflow statement for Onyx Biotec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 38 | 25.5 | 40.5 | 64.8 |
| Depreciation | ||||
| Non-Cash Items | 6.95 | 6.01 | 22.4 | 15.6 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -54.5 | -26.9 | -70.3 | -96.6 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 4.86 | 19.5 | 15.2 | 14.2 |
| Capital Expenditures | -57.9 | -227 | -32.2 | -10.5 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0.098 | 0.651 | 0.748 | 17.1 |
| Sale of Fixed Assets | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -57.8 | -227 | -31.5 | 6.56 |
| Financing Cash Flow Items | -5.15 | -5.55 | -21.1 | -19.9 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 52 | 164 | 30.9 | 50.7 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.926 | -42.9 | 14.6 | 71.5 |